Advances in pre-hospital care - operational experiences from the Melbourne mobile stroke unit

Abstract

Mobile stroke units (MSU) are specially designed ambulances with CT imaging capability able to provide faster pre-hospital care to patients in the community. The Melbourne Mobile Stroke Unit is the first MSU service in the Australian region, commencing operations in 2017 in central metropolitan Melbourne. This review describes the challenges of setting up the MSU in a unique Australian setting and initial clinical efficacy of pre-hospital MSU treatment and triage on ischemic and hemorrhagic stroke. We also discuss the current technological and operational limitations of the MSU service and directions for future research.

Keywords

Stroke / treatment / thrombolysis / intracerebral hemorrhage

References

[1] Audebert H,Hussain MS.The PRE-hospital Stroke Treatment Organization..Int J Stroke2017;12:932-40

[2] Zhao H,Easton D.Melbourne mobile stroke unit and reperfusion therapy: greater clinical impact of thrombectomy than thrombolysis..Stroke2020;51:922-30

[3] Walter S,Haass A.Bringing the hospital to the patient: first treatment of stroke patients at the emergency site..PLoS One2010;5:e13758 PMCID:PMC2966432

[4] Ebinger M,Wendt M.Effect of the use of ambulance-based thrombolysis on time to thrombolysis in acute ischemic stroke: a randomized clinical trial..JAMA2014;311:1622-31

[5] Parker SA,Wu TC.Establishing the first mobile stroke unit in the United States..Stroke2015;46:1384-91

[6] Zaidat OO,Sultan-Qurraie A.Diurnal variations in the first 24/7 mobile stroke unit..Stroke2019;50:1911-4

[7] Parker SA,Bowry R.Enhanced dispatch and rendezvous doubles the catchment area and number of patients treated on a mobile stroke unit..J Stroke Cerebrovasc Dis2020;29:104894

[8] Zhao H,Coote S.Ambulance clinical triage for acute stroke treatment: paramedic triage algorithm for large vessel occlusion..Stroke2018;49:945-51

[9] Ebinger M,Wendt M.Effects of golden hour thrombolysis: a prehospital acute neurological treatment and optimization of medical care in stroke (PHANTOM-S) substudy..JAMA Neurol2015;72:25-30

[10] Kunz A,Geisler F.Functional outcomes of pre-hospital thrombolysis in a mobile stroke treatment unit compared with conventional care: an observational registry study..Lancet Neurol2016;15:1035-43

[11] Audebert H,Siegerink B.The effects of Mobile Stroke Units on functional outcome after cerebral ischemia: B_PROUD. International Stroke Conference2020;Los Angeles, USA

[12] Bowry R,Rajan SS.Benefits of stroke treatment using a mobile stroke unit compared with standard management: the BEST-MSU study run-in phase..Stroke2015;46:3370-4

[13] Shownkeen H.,Crumlett H..E-112 a single center comparison of stroke treatment times: impact of a mobile stroke unit..J Neurointerv Surg2018;10:A103-4

[14] Lin E.,Goins-Whitmore J.,Zaidat O.World’s first 24/7 mobile stroke unit: initial 6-month experience at Mercy Health in Toledo, Ohio..Front Neurol2018;9:283 PMCID:PMC5966532

[15] Kim JT,Smith EE.Treatment with tissue plasminogen activator in the golden hour and the shape of the 4.5-hour time-benefit curve in the National United States Get with the guidelines-stroke population..Circulation2017;135:128-39

[16] Zhao H,Pesavento L.Prehospital idarucizumab prior to intravenous thrombolysis in a mobile stroke unit..Int J Stroke2019;14:265-9

[17] Fassbender K,Walter S,Ragoschke-Schumm A.Mobile stroke units for prehospital thrombolysis, triage, and beyond: benefits and challenges..Lancet Neurol2017;16:227-37

[18] Nogueira RG,Haussen DC.Thrombectomy 6 to 24 hours after stroke with a mismatch between deficit and infarct..N Engl J Med2018;378:11-21

[19] Albers GW,Kemp S.Thrombectomy for stroke at 6 to 16 hours with selection by perfusion imaging..N Engl J Med2018;378:708-18 PMCID:PMC6590673

[20] Czap AL,Parker SA.Emergency department door-to-puncture time since 2014..Stroke2019;50:1774-80

[21] Patel P,Mullaguri N.Abstract WP226: bypassing interhospital transfers for large vessel occlusions in the era of mobile stroke units..Stroke2018;49:

[22] Kerrigan D,Nour M,Uchino K.Abstract TMP19: mobile stroke units have higher rates of recanalization of emergent large vessel occlusion..Stroke2019;50:

[23] Saver JL,van der Lugt A.Time to treatment with endovascular thrombectomy and outcomes from ischemic stroke: a meta-analysis..JAMA2016;316:1279-88

[24] Meretoja A,Saver JL.Stroke thrombolysis: save a minute, save a day..Stroke2014;45:1053-8

[25] Meretoja A,Tatlisumak T,Churilov L.Endovascular therapy for ischemic stroke: save a minute-save a week..Neurology2017;88:2123-7

[26] Emberson J,Lyden P.Effect of treatment delay, age, and stroke severity on the effects of intravenous thrombolysis with alteplase for acute ischaemic stroke: a meta-analysis of individual patient data from randomised trials..Lancet2014;384:1929-35 PMCID:PMC4441266

[27] Al-shahi Salman R,Lee RJ.Absolute risk and predictors of the growth of acute spontaneous intracerebral haemorrhage: a systematic review and meta-analysis of individual patient data..Lancet Neurol2018;17:885-94 PMCID:PMC6143589

[28] Sprigg N,Appleton JP.Tranexamic acid for hyperacute primary intracerebral haemorrhage (TICH-2): an international randomised, placebo-controlled, phase 3 superiority trial..Lancet2018;391:2107-21 PMCID:PMC5976950

[29] Gladstone DJ,Demchuk AM.Effect of recombinant activated coagulation factor VII on hemorrhage expansion among patients with spot sign-positive acute intracerebral hemorrhage: the SPOTLIGHT and STOP-IT randomized clinical trials..JAMA Neurol2019;76:1493-501 PMCID:PMC6704754

[30] Mayer SA,Begtrup K.Efficacy and safety of recombinant activated factor VII for acute intracerebral hemorrhage..N Engl J Med2008;358:2127-37

[31] Li Q,Qureshi AI.Ultra-early blood pressure reduction attenuates hematoma growth and improves outcome in intracerebral hemorrhage..Ann Neurol2020;88:388-95

[32] Connolly SJ,Eikelboom JW.Full study report of andexanet alfa for bleeding associated with factor Xa inhibitors..N Engl J Med2019;380:1326-35 PMCID:PMC6699827

[33] Huttner HB,Hartmann M.Hematoma growth and outcome in treated neurocritical care patients with intracerebral hemorrhage related to oral anticoagulant therapy: comparison of acute treatment strategies using vitamin K, fresh frozen plasma, and prothrombin complex concentrates..Stroke2006;37:1465-70

[34] Abid KA,Patel HC,Tyrrell PJ.Which factors influence decisions to transfer and treat patients with acute intracerebral haemorrhage and which are associated with prognosis? A retrospective cohort study..BMJ Open2013;3:e003684 PMCID:PMC3884585

[35] John S,Cerejo R.Brain imaging using mobile CT: current status and future prospects..J Neuroimaging2016;26:5-15

[36] Ma H,Parsons MW.Thrombolysis guided by perfusion imaging up to 9 hours after onset of stroke..N Engl J Med2019;380:1795-803

[37] Campbell BC,Desmond PM.CT perfusion improves diagnostic accuracy and confidence in acute ischaemic stroke..J Neurol Neurosurg Psychiatry2013;84:613-8

[38] Campbell BCV.Stroke..Lancet2020;396:129-42

[39] Bowry R,Yamal JM.Time to decision and treatment with tPA (tissue-type plasminogen activator) using telemedicine versus an onboard neurologist on a mobile stroke unit..Stroke2018;49:1528-30

[40] Winter B,Waldschmidt C.4G versus 3G-enabled telemedicine in prehospital acute stroke care..Int J Stroke2019;14:620-9

[41] Krebes S,Baumann AM.Development and validation of a dispatcher identification algorithm for stroke emergencies..Stroke2012;43:776-81

[42] Kim J,Zhao H.Economic evaluation of the Melbourne mobile stroke unit..Int J Stroke2020;1747493020929944:

[43] Wang S.,Merlin T.Comparing the ICERs in medicine reimbursement submissions to NICE and PBAC-Does the presence of an explicit threshold affect the ICER proposed?.Value Health2018;21:938-43

[44] Gyrd-Hansen D,Bollweg K,Ebinger M.Cost-effectiveness estimate of prehospital thrombolysis: results of the PHANTOM-S study..Neurology2015;84:1090-7

[45] Reimer AP,Hustey FM.Cost-consequence analysis of mobile stroke units vs. standard prehospital care and transport..Front Neurol2019;10:1422 PMCID:PMC7028763